A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)
Status:
Recruiting
Trial end date:
2022-04-06
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to learn about the side effects of LY3437943 when given to
Japanese participants with type 2 diabetes mellitus. Blood tests will be performed to
investigate how the body processes the study drug and how the study drug affects the body.
Each enrolled participant will receive injections of LY3437943 or placebo given just under
the skin. For each participant, the study will last up to 5 months, inclusive of screening
and will include 16 visits to the study center.